<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Cheney Research &#187; Chronic Fatigue Syndrome</title>
	<atom:link href="http://www.cheneyresearch.com/category/public/chronic-fatigue-syndrome-public/feed" rel="self" type="application/rss+xml" />
	<link>http://www.cheneyresearch.com</link>
	<description></description>
	<lastBuildDate>Mon, 26 Apr 2010 21:00:31 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>A paucity of autoimmune disease and hypertension in CFS</title>
		<link>http://www.cheneyresearch.com/2009/05/cfs-and-autoimmunity-1</link>
		<comments>http://www.cheneyresearch.com/2009/05/cfs-and-autoimmunity-1#comments</comments>
		<pubDate>Sun, 03 May 2009 22:16:00 +0000</pubDate>
		<dc:creator>pcheney</dc:creator>
				<category><![CDATA[Chronic Fatigue Syndrome]]></category>
		<category><![CDATA[Autoimmunity]]></category>
		<category><![CDATA[Hypertension]]></category>
		<category><![CDATA[T-cell activation]]></category>
		<category><![CDATA[TGF beta-1]]></category>

		<guid isPermaLink="false">http://cheneyresearch.com/?p=37</guid>
		<description><![CDATA[There is little true autoimmune disease seen in CFS as distinct from autoantibody formation without organ destruction which is more common.  Also, there is a significant paucity of hypertension seen in my CFS cohort at less than 1% of all patients with CFS in my practice.]]></description>
			<content:encoded><![CDATA[<p>It is interesting that T-cell activation is such as big part of CFS and hence TGF Beta-1 activation in response to T-cell activation.  Yet,  there is little true autoimmune disease seen in CFS as distinct from autoantibody formation without organ </p>
]]></content:encoded>
			<wfw:commentRss>http://www.cheneyresearch.com/2009/05/cfs-and-autoimmunity-1/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Antibiotics and Dysbiosis</title>
		<link>http://www.cheneyresearch.com/2009/05/antibiotics-and-dysbiosis</link>
		<comments>http://www.cheneyresearch.com/2009/05/antibiotics-and-dysbiosis#comments</comments>
		<pubDate>Sun, 03 May 2009 22:13:44 +0000</pubDate>
		<dc:creator>pcheney</dc:creator>
				<category><![CDATA[Chronic Fatigue Syndrome]]></category>
		<category><![CDATA[antibiotics]]></category>
		<category><![CDATA[dysbiosis]]></category>
		<category><![CDATA[Jeremy Nicholson PhD]]></category>
		<category><![CDATA[metabolome]]></category>
		<category><![CDATA[xenobiotics]]></category>

		<guid isPermaLink="false">http://cheneyresearch.com/?p=34</guid>
		<description><![CDATA[I would agree that some sort of gut dysbiosis strategy is appropriate but more as part of a larger strategy which also addresses redox control points as well as human phenotypic and genotypic corruption.  There is as yet, no clear consensus on treating this gut dysbiosis, so I take a pretty conservative approach that follows a 3R strategy (remove, repair and replace) as well as a modified elimination diet and especially fructose elimination.]]></description>
			<content:encoded><![CDATA[<p>There are reports of improvement in CFS patients based on various approaches to improving gut dysbiosis or gut microbial corruption.  Most approaches use a combination of removal of the current gut ecology and the replacement of those corrupted microbial elements </p>
]]></content:encoded>
			<wfw:commentRss>http://www.cheneyresearch.com/2009/05/antibiotics-and-dysbiosis/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CFS and the absence of autoimmune disease &#8211; ? NO elevation</title>
		<link>http://www.cheneyresearch.com/2009/05/cfs-and-autoimmunity-2</link>
		<comments>http://www.cheneyresearch.com/2009/05/cfs-and-autoimmunity-2#comments</comments>
		<pubDate>Sat, 02 May 2009 22:17:01 +0000</pubDate>
		<dc:creator>pcheney</dc:creator>
				<category><![CDATA[Chronic Fatigue Syndrome]]></category>
		<category><![CDATA[autoimmune disease]]></category>
		<category><![CDATA[Lupus]]></category>
		<category><![CDATA[MS]]></category>
		<category><![CDATA[nitric oxide]]></category>
		<category><![CDATA[RA]]></category>

		<guid isPermaLink="false">http://cheneyresearch.com/?p=39</guid>
		<description><![CDATA[Very interesting is the relationship of high nitric oxide (NO) to a low incidence of autoimmune disease.  In CFS patients, actual autoimmune disease is very rare as is hypertension.]]></description>
			<content:encoded><![CDATA[<p>Very interesting is the relationship of high nitric oxide (NO) to a low incidence of autoimmune disease.  In CFS patients, actual autoimmune disease is very rare as is hypertension.  There is also the suggestion of high levels of NO in </p>
]]></content:encoded>
			<wfw:commentRss>http://www.cheneyresearch.com/2009/05/cfs-and-autoimmunity-2/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Antibiotics in CFS</title>
		<link>http://www.cheneyresearch.com/2009/04/antibiotics-in-cfs</link>
		<comments>http://www.cheneyresearch.com/2009/04/antibiotics-in-cfs#comments</comments>
		<pubDate>Fri, 03 Apr 2009 22:09:50 +0000</pubDate>
		<dc:creator>pcheney</dc:creator>
				<category><![CDATA[Chronic Fatigue Syndrome]]></category>
		<category><![CDATA[antibiotics]]></category>
		<category><![CDATA[biological terrain issues]]></category>
		<category><![CDATA[Lyme Disease]]></category>
		<category><![CDATA[stem cell therapy]]></category>

		<guid isPermaLink="false">http://cheneyresearch.com/?p=32</guid>
		<description><![CDATA[To me, CFS is best viewed as a very complex terrain issue and that microbes are simply taking advantage of this fact so that reductionism to drugs or pharmaceuticals directed against single agents or pathways will be a poor therapeutic choice except perhaps early in the illness and in the occasional patient who is much less complex.]]></description>
			<content:encoded><![CDATA[<p>There are some practitioners that claim significant improvement in CFS case of 20 points or more on the Karnofsky performance score (KPS) which in my practice, with an average KPS score of 60, would be a functional cure. Almost all of </p>
]]></content:encoded>
			<wfw:commentRss>http://www.cheneyresearch.com/2009/04/antibiotics-in-cfs/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
